SC: Bribe Recovery Alone Cannot Prove Guilt without Proof of Demand under PC Act || SC: Cut Power, Water to Bulk Waste Generators Violating Solid Waste Rules || SC: RPF Employee Who Conceals Criminal Case Can be Discharged at Any Stage || SC: Police can Register FIR Despite Magistrate Rejecting S.156(3) CrPC Application || SC: Criminal Acquittal Alone Cannot Prove Absence of Negligence in Accident Claims || SC: Referral Fees Earned By Auto Dealers for Bank, Insurance Promotion Taxable as Service Tax || Supreme Court Revisits the definition of “Industry”: 9-Judge Bench Reformulates the 1978 Triple Test || Delhi HC: Exam Integrity is a Shared Duty of Candidates and Authorities || Delhi High Court: POCSO Allows Child Witness Cross-Examination but Bars Aggressive Questioning || Kerala HC: Christian Women May File Divorce Pleas Where They Reside

Delhi HC Issues Notice in PIL Seeking Selling of Remdesivir by All Pharma Firms in Domestic Market - (04 May 2021)

CIVIL

Delhi High Court has issued notice to the Centre and various pharma majors asking them to respond to a Public Interest Litigation seeking that all drug firms involved in the making Remdesivir be allowed to sell it in the domestic market. The Court has issued the notice to the Health Ministry, Central Drugs Standard Control Organisation, Director General of Foreign Trade, and various pharma companies, like Cipla, Zydus, and Cadila, seeking their stand on the issue.

Tags : DELHI HIGH COURT SELLING OF REMDESIVIR

Share :